A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis

Journal of the American Society of Nephrology

Volumn 18, Issue 2, 2007, Pages 472-484

  Ma, Frank Y ^a   Flanc, Robert S ^a,b   Tesch, Greg H ^a,b   Han, Yingjie ^a,b   Atkins, Robert C ^a,b   Bennett, Brydon L ^c   Friedman, Glenn C ^c   Fan, Jui Hsiang ^c   Nikolic Paterson, David J ^a,b  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c CELGENE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CC 401; COLLAGEN TYPE 4; CONNECTIVE TISSUE GROWTH FACTOR; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE 9; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; IN VITRO STUDY; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY TUBULE; MOUSE; MYOFIBROBLAST; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; URETER OBSTRUCTION; WESTERN BLOTTING;

EID: 33846689276     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006060604     Document Type: Article

References (54)

1. Manning AM, Davis RJ: Targeting JNK for therapeutic benefit: From junk to gold? Nat Rev Drug Discov 2: 554-565, 2003
2. Bogoyevitch MA, Boehm I, Oakley A, Ketterman AJ, Barr RK: Targeting the JNK MAPK cascade for inhibition: Basic science and therapeutic potential. Biochim Biophys Acta 1697: 89-101, 2004
3. Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR: Phosphorylation of c-jun mediated by MAP kinases. Nature 353: 670-674, 1991
4. Minden A, Lin A, Smeal T, Derijard B, Cobb M, Davis R, Karin M: c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol Cell Biol 14: 6683-6688, 1994
5. Vinciguerra M, Vivacqua A, Fasanella G, Gallo A, Cuozzo C, Morano A, Maggiolini M, Musti AM: Differential phosphorylation of c-Jun and JunD in response to the epidermal growth factor is determined by the structure of MAPK targeting sequences. J Biol Chem 279: 9634-9641, 2004
6. Wang YN, Chen YJ, Chang WC: Activation of extracellular signal-regulated kinase signaling by epidermal growth factor mediates c-Jun activation and p300 recruitment in keratin 16 gene expression. Mol Pharmacol 69: 85-98, 2006
7. Deng Y, Ren X, Yang L, Lin Y, Wu X: A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell 115: 61-70, 2003
8. Yu C, Minemoto Y, Zhang J, Liu J, Tang F, Bui TN, Xiang J, Lin A: JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol Cell 13: 329-340, 2004
9. Liu J, Lin A: Role of JNK activation in apoptosis: A double-edged sword. Cell Res 15: 36-42, 2005
10. Yang DD, Kuan CY, Whitmarsh AJ, Rincon M, Zheng TS, Davis RJ, Rakic P, Flavell RA: Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389: 865-870, 1997
11. Uehara T, Bennett B, Sakata ST, Satoh Y, Bilter GK, Westwick JK, Brenner DA: JNK mediates hepatic ischemia reperfusion injury. J Hepatol 42: 850-859, 2005
12. Uehara T, Xi Peng X, Bennett B, Satoh Y, Friedman G, Currin R, Brenner DA, Lemasters J: c-Jun N-terminal kinase mediates hepatic injury after rat liver transplantation. Transplantation 78: 324-332, 2004
13. Chan ED, Riches DW: IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line. Am J Physiol Cell Physiol 280: C441-C450, 2001
14. Han Z, Boyle DL, Chang L, Bennett B, Karin M, Yang L, Manning AM, Firestein GS: c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 108: 73-81, 2001
15. Dong C, Yang DD, Wysk M, Whitmarsh AJ, Davis RJ, Flavell RA: Defective T cell differentiation in the absence of Jnk1. Science 282: 2092-2095, 1998
16. Dong C, Yang DD, Tournier C, Whitmarsh AJ, Xu J, Davis RJ, Flavell RA: JNK is required for effector T-cell function but not for T-cell activation. Nature 405: 91-94, 2000
17. Yang DD, Conze D, Whitmarsh AJ, Barrett T, Davis RJ, Rincon M, Flavell RA: Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. Immunity 9: 575-585, 1998
18. Hocevar BA, Brown TL, Howe PH: TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J 18: 1345-1356, 1999
19. Utsugi M, Dobashi K, Ishizuka T, Masubuchi K, Shimizu Y, Nakazawa T, Mori M: C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts. Am J Respir Cell Mol Biol 28: 754-761, 2003
20. Peng H, Takano T, Papillon J, Bijian K, Khadir A, Cybulsky AV: Complement activates the c-Jun N-terminal kinase/stress-activated protein kinase in glomerular epithelial cells. J Immunol 169: 2594-2601, 2002
21. Yang CW, Ahn HJ, Jung JY, Kim WY, Li C, Choi BS, Kim HW, Kim YS, Moon IS, Kim J, Bang BK: Preconditioning with cyclosporine A or FK506 differentially regulates mitogen-activated protein kinase expression in rat kidneys with ischemia/reperfusion injury. Transplantation 75: 20-24, 2003
22. Fujita H, Omori S, Ishikura K, Hida M, Awazu M: ERK and p38 mediate high-glucose-induced hypertrophy and TGF-beta expression in renal tubular cells. Am J Physiol Renal Physiol 286: F120-F126, 2004
23. Yokoi H, Mukoyama M, Nagae T, Mori K, Suganami T, Sawai K, Yoshioka T, Koshikawa M, Nishida T, Takigawa M, Sugawara A, Nakao K: Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol 15: 1430-1440, 2004
24. Miyajima A, Chen J, Lawrence C, Ledbetter S, Soslow RA, Stern J, Jha S, Pigato J, Lemer ML, Poppas DP, Vaughan ED, Felsen D: Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 58: 2301-2313, 2000
25. Isaka Y, Tsujie M, Ando Y, Nakamura H, Kaneda Y, Imai E, Hori M: Transforming growth factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney Int 58: 1885-1892, 2000
26. Shappell SB, Gurpinar T, Lechago J, Suki WN, Truong LD: Chronic obstructive uropathy in severe combined immunodeficient (SCID) mice: Lymphocyte infiltration is not required for progressive tubulointerstitial injury. J Am Soc Nephrol 9: 1008-1017, 1998
27. Masaki T, Foti R, Hill PA, Ikezumi Y, Atkins RC, Nikolic-Paterson DJ: Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney. Kidney Int 63: 1256-1264, 2003
28. Pillebout E, Weitzman JB, Burtin M, Martino C, Federici P, Yaniv M, Friedlander G, Terzi F: JunD protects against chronic kidney disease by regulating paracrine mitogens. J Clin Invest 112: 843-852, 2003
29. Engel ME, McDonnell MA, Law BK, Moses HL: Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J Biol Chem 274: 37413-37420, 1999
30. Huang Z, Tunnacliffe A: Response of human cells to desiccation: Comparison with hyperosmotic stress response. J Physiol 558: 181-191, 2004
31. Ingram AJ, Ly H, Thai K, Kang M, Scholey JW: Activation of mesangial cell signaling cascades in response to mechanical strain. Kidney Int 55: 476-485, 1999
32. Koh YH, Che W, Higashiyama S, Takahashi M, Miyamoto Y, Suzuki K, Taniguchi N: Osmotic stress induces HB-EGF gene expression via Ca(2+)/Pyk2/JNK signal cascades in rat aortic smooth muscle cells. J Biochem (Tokyo) 130: 351-358, 2001
33. Malek AM, Goss GG, Jiang L, Izumo S, Alper SL: Mannitol at clinical concentrations activates multiple signaling pathways and induces apoptosis in endothelial cells. Stroke 29: 2631-2640, 1998
34. Martineau LC, Gardiner PF: Insight into skeletal muscle mechanotransduction: MAPK activation is quantitatively related to tension. J Appl Physiol 91: 693-702, 2001
35. Jennings D, Stavris K, Counihan T, Gardiner I, Factor S, Evans S, Feigin A, Shannon B, Fernandez H: The safety and tolerability of a mixed lineage kinase inhibitor (CEP-1347) in PD. Neurology 62: 330-332, 2004
36. Kaneto H, Morrissey J, Klahr S: Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 44: 313-321, 1993
37. Naito T, Masaki T, Nikolic-Paterson DJ, Tanji C, Yorioka N, Kohno N: Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: A mechanism for activation of latent TGF-beta1. Am J Physiol Renal Physiol 286: F278-F287, 2004
38. Wu Z, Zhou Q, Lan Y, Wang Y, Xu X, Jin H: AP-1 complexes mediate oxidized LDL-induced overproduction of TGF-beta(1) in rat mesangial cells. Cell Biochem Funct 22: 237-247, 2004
39. Fukuda K, Yoshitomi K, Yanagida T, Tokumoto M, Hirakata H: Quantification of TGF-beta1 mRNA along rat nephron in obstructive nephropathy. Am J Physiol Renal Physiol 281: F513-F521, 2001
40. Le Meur Y, Tesch GH, Hill PA, Mu W, Foti R, Nikolic-Paterson DJ, Atkins RC: Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway. J Leukoc Biol 72: 530-537, 2002
41. Yang L, Scott PG, Giuffre J, Shankowsky HA, Ghahary A, Tredget EE: Peripheral blood fibrocytes from burn patients: Identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 82: 1183-1192, 2002
42. Evans RA, Tian YC, Steadman R, Phillips AO: TGF-beta1-mediated fibroblast-myofibroblast terminal, differentiation-the role of Smad proteins. Exp Cell Res 282: 90-100, 2003
43. Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY: Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 56: 1455-1467, 1999
44. Iwano M, Neilson EG: Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens 13: 279-284, 2004
45. Du L, Lyle CS, Hall-Obey TB, Gaarde WA, Muir JA, Bennett BL, Chambers TC: Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: Evidence that mitotic Bcl-2 phosphorylation is JNK-independent. J Biol Chem 279: 11957-11966, 2004
46. Kaiser RA, Liang Q, Bueno OF, Huang Y, Lackey T, Klevitsky R, Hewett TE, Molkentin JD: Genetic inhibition or activation of JNK1/2 each protect the myocardium from ischemia-reperfusion-induced cell death in vivo. J Biol Chem 280: 32602-32608, 2005
47. Liu J, Minemoto Y, Lin A: c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis. Mol Cell Biol 24: 10844-10856, 2004
48. Pat BK, Cuttle L, Watters D, Yang T, Johnson DW, Gobe GC: Fibrogenic stresses activate different mitogen-activated protein kinase pathways in renal epithelial, endothelial or fibroblast cell populations. Nephrology (Carlton) 8: 196-204, 2003
49. Arany I, Megyesi JK, Kaneto H, Tanaka S, Safirstein RL: Activation of ERK or inhibition of JNK ameliorates H2O2 cytotoxicity in mouse renal proximal tubule cells. Kidney Int 65: 1231-1239, 2004
50. Nguyen HT, Hsieh MH, Gaborro A, Tinloy B, Phillips C, Adam RM: JNK/SAPK and p38 SAPK-2 mediate mechanical stretch-induced apoptosis via caspase-3 and -9 in NRK-52E renal epithelial cells. Nephron Exp Nephrol 102: e49-e61, 2006
51. Lange-Sperandio B, Fulda S, Vandewalle A, Chevalier RL: Macrophages induce apoptosis in proximal tubule cells. Pediatr Nephrol 18: 335-341, 2003
52. Ikezumi Y, Hurst L, Atkins RC, Nikolic-Paterson DJ: Macrophage-mediated renal injury is dependent on signaling via the JNK pathway. J Am Soc Nephrol 15: 1775-1784, 2004
53. Stambe C, Atkins RC, Tesch GH, Masaki T, Schreiner GF, Nikolic-Paterson DJ: The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis. J Am Soc Nephrol 15: 370-379, 2004
54. Morton S, Davis RJ, McLaren A, Cohen P: A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J 22: 3876-3886, 2003